Switching drugs could help macular degeneration patients
July 25, 2018
M.D. Magazine covered a UCLA Stein Eye Institute study by Dr. Michael Ip finding that macular degeneration patients who didn’t respond well to injections of the drug Avastin experienced improvement in macular thickness and visual acuity when their medication was switched to Eylea or Regeneron. A professor of ophthalmology at the David Geffen School of Medicine at UCLA, Ip presented the findings to the American Society of Retinal Society’s annual meeting.
